Clinical Trial Update: Stereotactic Radiotherapy for Oligometastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for stereotactic radiotherapy in oligometastatic prostate cancer (Phase 1/Phase 2) with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatic Neoplasms

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN